Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
Wellnex Life Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | AU$0.023 |
52 Week High | AU$0.035 |
52 Week Low | AU$0.017 |
Beta | 0.69 |
11 Month Change | -8.00% |
3 Month Change | -20.69% |
1 Year Change | n/a |
33 Year Change | -78.10% |
5 Year Change | -94.10% |
Change since IPO | -88.50% |
Recent News & Updates
Shareholder Returns
WNX | AU Food | AU Market | |
---|---|---|---|
7D | 9.5% | 2.6% | 0.7% |
1Y | n/a | 12.1% | 10.5% |
Return vs Industry: Insufficient data to determine how WNX performed against the Australian Food industry.
Return vs Market: Insufficient data to determine how WNX performed against the Australian Market.
Price Volatility
WNX volatility | |
---|---|
WNX Average Weekly Movement | 11.3% |
Food Industry Average Movement | 7.2% |
Market Average Movement | 8.4% |
10% most volatile stocks in AU Market | 17.4% |
10% least volatile stocks in AU Market | 3.5% |
Stable Share Price: WNX's share price has been volatile over the past 3 months.
Volatility Over Time: WNX's weekly volatility (11%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2011 | n/a | George Karafotias | wellnexlife.com.au |
Wellnex Life Limited develops health and wellness solutions in Australia. The company provides iron gummies under The Iron Company brand; natural energy products under the Wakey Wakey brand; sleep aid products under the Nighty Night brand; teeth whitening products under Mr Bright brand; over-the-counter medicines under the Pharmacy Own brand; and pain relief product under the Wagner Liquigesics brand. In addition, the company offers organic baby skincare, aromatherapy essential oils, and domestic cleaning products, as well as provides provides contract manufacturing services.
Wellnex Life Limited Fundamentals Summary
WNX fundamental statistics | |
---|---|
Market cap | AU$32.24m |
Earnings (TTM) | -AU$14.74m |
Revenue (TTM) | AU$16.94m |
1.9x
P/S Ratio-2.2x
P/E RatioIs WNX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
WNX income statement (TTM) | |
---|---|
Revenue | AU$16.94m |
Cost of Revenue | AU$12.27m |
Gross Profit | AU$4.67m |
Other Expenses | AU$19.41m |
Earnings | -AU$14.74m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.011 |
Gross Margin | 27.56% |
Net Profit Margin | -87.02% |
Debt/Equity Ratio | 147.8% |
How did WNX perform over the long term?
See historical performance and comparison